Understanding racial differences in recovery after critical illness
Official title: Examining Racial Disparities in Predictive Modeling Among Survivors of Critical Illness
Funded at University of Pittsburgh at Pittsburgh · NIH-10901179 · Data updated 2026-11-12
This study is looking at how differences in race might impact the recovery of people who have survived serious illnesses, with the goal of making sure everyone gets the best care possible after leaving the hospital.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $90,932 |
| NIH project number | 1F32MD019534-01 |
| Project ID | NIH-10901179 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are survivors of critical illness, particularly those from racially diverse backgrounds who may face disparities in healthcare access and outcomes.
✕Less likely to help
Patients who have not experienced critical illness or those outside the targeted racial and ethnic groups may not benefit from this research.
What this research studies
This research investigates how racial disparities affect the recovery of patients who have survived critical illnesses. It focuses on identifying biases in predictive tools that assess the risk of complications and readmissions among these patients. By analyzing data from various healthcare systems, the research aims to improve post-acute care interventions and outcomes for survivors. The study will specifically look at mortality rates, readmission rates, and the number of days patients are free from hospital care within 90 days of their critical illness.
Why it matters
Potential benefit: If successful, this research could lead to more equitable healthcare interventions for survivors of critical illness, ultimately improving recovery outcomes for racially diverse patient populations.
How similar studies have gone: Previous research has shown success in addressing healthcare disparities and improving outcomes for diverse populations, indicating that this approach has potential for meaningful impact.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Naiditch, Hiam — University of Pittsburgh at Pittsburgh
- Study coordinator: Naiditch, Hiam
Related research
Other NIH-funded projects on the same topics.
-
Glucocorticoids and critical illness outcomes in ICU patients
A researcher team at Columbia University will study how glucocorticoids affect short- and long-term outcomes for people who survive critical illness, including mental health and recovery aspects.
-
REPAIR-ICU: Understanding aging-like changes after critical illness to help ICU survivors
This grant studies how surviving an ICU stay triggers aging-related changes in the body and tests interventions to help people recover.
-
Understanding how individual responses to treatments vary in ARDS and sepsis
This grant aims to help clinicians predict which patients with ARDS or sepsis will benefit most from specific treatments by using advanced computer approaches.
-
Myeloid-Derived Suppressor Cells in Immunological Endotyping and Intervention for Chronic Critical Illness after Sepsis
Aimed at people who have survived sepsis after surgery, this grant seeks to understand why some patients develop long-term organ problems and how to tailor treatments to their immune responses.
-
Molecular rules of capillary leak in seriously ill kids
A study looking at why blood vessels become leaky in severely ill children and how that leads to organ failure.
-
Heme-Driven Immune Dysregulation in Critical Illness
Researchers are studying how free heme from red blood cell breakdown affects the immune system in people with sepsis or chronic blood disorders, with the aim of guiding better treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.